Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > All Brazilian businesses that have a link to LABS
View:
Post by Lemoyne on Oct 29, 2024 3:16pm

All Brazilian businesses that have a link to LABS

https://consultas.anvisa.gov.br/#/empresas/empresasInternacionais/i/965485/?pais=37
Comment by Lemoyne on Oct 29, 2024 3:17pm
Amongst which, Teuto seems to be the biggest one and added in july. (LABS mentioned their new brazilian pharma deal occurred in july.)
Comment by QContinuum1 on Oct 29, 2024 3:32pm
Don't know much about Active Pharma, but Caldic or Caldic/GTM look like they're huge in comparison to even Teuto!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities